-
1
-
-
0037444761
-
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
-
Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin J, Li H, Yasui K, Takeuchi M, Makita M, Takasawa S, Okamoto H, Watanabe T, Yamamoto H. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J. 2003;370:1097-1109.
-
(2003)
Biochem J
, vol.370
, pp. 1097-1109
-
-
Yonekura, H.1
Yamamoto, Y.2
Sakurai, S.3
Petrova, R.G.4
Abedin, J.5
Li, H.6
Yasui, K.7
Takeuchi, M.8
Makita, M.9
Takasawa, S.10
Okamoto, H.11
Watanabe, T.12
Yamamoto, H.13
-
2
-
-
33646765537
-
Development of an ELISA for esRAGE and its application to type 1 diabetic patients
-
Sakurai S, Yamamoto Y, Tamei H, Matsuki H, Obata KI, Hui L, Miura J, Osawa M, Uchigata Y, Iwamoto Y, Watanabe T, Yonekura H, Yamamoto H. Development of an ELISA for esRAGE and its application to type 1 diabetic patients. Diabetes Res Clin Pract. 2006;73:158-165.
-
(2006)
Diabetes Res Clin Pract
, vol.73
, pp. 158-165
-
-
Sakurai, S.1
Yamamoto, Y.2
Tamei, H.3
Matsuki, H.4
Obata, K.I.5
Hui, L.6
Miura, J.7
Osawa, M.8
Uchigata, Y.9
Iwamoto, Y.10
Watanabe, T.11
Yonekura, H.12
Yamamoto, H.13
-
3
-
-
9644302477
-
Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)
-
Hanford LE, Enghild JJ, Valnickova Z, Petersen SV, Schaefer LM, Schaefer TM, Reinhart TA, Oury TD. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J Biol Chem. 2004;279:50019-50024.
-
(2004)
J Biol Chem
, vol.279
, pp. 50019-50024
-
-
Hanford, L.E.1
Enghild, J.J.2
Valnickova, Z.3
Petersen, S.V.4
Schaefer, L.M.5
Schaefer, T.M.6
Reinhart, T.A.7
Oury, T.D.8
-
4
-
-
33644808985
-
Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis
-
Koyama H, Shoji T, Yokoyama H, Motoyama K, Mori K, Fukumoto S, Emoto M, Shoji T, Tamei H, Matsuki H, Sakurai S, Yamamoto Y, Yonekura H, Watanabe T, Yamamoto H, Nishizawa Y. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2005;12:2587-2593.
-
(2005)
Arterioscler Thromb Vasc Biol
, vol.12
, pp. 2587-2593
-
-
Koyama, H.1
Shoji, T.2
Yokoyama, H.3
Motoyama, K.4
Mori, K.5
Fukumoto, S.6
Emoto, M.7
Shoji, T.8
Tamei, H.9
Matsuki, H.10
Sakurai, S.11
Yamamoto, Y.12
Yonekura, H.13
Watanabe, T.14
Yamamoto, H.15
Nishizawa, Y.16
-
5
-
-
25144467605
-
Expression profiling of endogenous secretory receptor for advanced glycation endoproducts in human organs
-
Chunmei C, Tsuneyama K, Kominami R, Shinohara H, Sakurai S, Yonekura H, Watanabe T, Takano Y, Yamamoto H, Yamamoto Y. Expression profiling of endogenous secretory receptor for advanced glycation endoproducts in human organs. Mod Pathol. 2005;18:1385-1396.
-
(2005)
Mod Pathol
, vol.18
, pp. 1385-1396
-
-
Chunmei, C.1
Tsuneyama, K.2
Kominami, R.3
Shinohara, H.4
Sakurai, S.5
Yonekura, H.6
Watanabe, T.7
Takano, Y.8
Yamamoto, H.9
Yamamoto, Y.10
-
6
-
-
33750590947
-
RAGE control of diabetic nephropathy in a mouse model: Effects of RAGE gene disruption and administration of low-molecular weight heparin
-
Myint KM, Yamamoto Y, Doi T, Kato I, Harashima A, Yonekura H, Watanabe T, Shinohara H, Takeuchi M, Tsuneyama K, Hashimoto N, Asano M, Takasawa S, Okamoto H, Yamamoto H. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin. Diabetes. 2006;55:2510-2522.
-
(2006)
Diabetes
, vol.55
, pp. 2510-2522
-
-
Myint, K.M.1
Yamamoto, Y.2
Doi, T.3
Kato, I.4
Harashima, A.5
Yonekura, H.6
Watanabe, T.7
Shinohara, H.8
Takeuchi, M.9
Tsuneyama, K.10
Hashimoto, N.11
Asano, M.12
Takasawa, S.13
Okamoto, H.14
Yamamoto, H.15
-
7
-
-
33847608713
-
Low circulating endogenous secretory receptor for AGEs (esRAGE) predicts cardiovascular mortality in patients with end-stage renal disease
-
Koyama H, Shoji T, Fukumoto S, Shinohara K, Shoji T, Emoto M, Mori K, Tahara H, Ishimura E, Kakiya R, Tabata T, Yamamoto H, Nishizawa Y. Low circulating endogenous secretory receptor for AGEs (esRAGE) predicts cardiovascular mortality in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol. 2007;27:147-153.
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, pp. 147-153
-
-
Koyama, H.1
Shoji, T.2
Fukumoto, S.3
Shinohara, K.4
Shoji, T.5
Emoto, M.6
Mori, K.7
Tahara, H.8
Ishimura, E.9
Kakiya, R.10
Tabata, T.11
Yamamoto, H.12
Nishizawa, Y.13
-
8
-
-
33847619668
-
Endogenous secretory receptor for advanced glycation endproducts levels are correlated with serum pentosidine and CML in patients with type 1 diabetes
-
Miura J, Yamamoto Y, Osawa M, Watanabe T, Yonekura H, Uchigata Y, Yamamoto H, Iwamoto Y. Endogenous secretory receptor for advanced glycation endproducts levels are correlated with serum pentosidine and CML in patients with type 1 diabetes. Arterioscler Thromb Vasc Biol. 2007;27:253-254.
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, pp. 253-254
-
-
Miura, J.1
Yamamoto, Y.2
Osawa, M.3
Watanabe, T.4
Yonekura, H.5
Uchigata, Y.6
Yamamoto, H.7
Iwamoto, Y.8
-
9
-
-
33745601096
-
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans
-
Geroldi D, Falcone C, Minoretti P, Emanuele E, Arra M, D'Angelo S. High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans. J Am Geriat Soc. 2006;54:1149.
-
(2006)
J Am Geriat Soc
, vol.54
, pp. 1149
-
-
Geroldi, D.1
Falcone, C.2
Minoretti, P.3
Emanuele, E.4
Arra, M.5
D'Angelo, S.6
|